Replies to post #589946 on NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

I agree.

October 27, 2022

Linda Liau

"This is our next SPORE trial (DC vaccine/poly-ICLC + anti-PD1 + CSF1-Ri in newly diagnosed GBM patients) but we haven't started it yet."

anti-PD1= Pembrolizumab 400 mg q 6 weeks

.

[georgebailey]

Flip- is it accurate to state that ICLC can be excluded in a small number of cases where hyper activation is not warranted ?

[georgebailey]

Flip- From your comment,Poly- iclc likely always be included, implies there’s a chance it won’t always be included. So, you hedged by saying “likely”.